Ofatumumab is a humanized anti-CD20 monoclonal antibody that induces B-cell lysis via ADCC and CDC. It is widely used in research applications, including in vitro B-cell depletion assays and in vivo models of autoimmune disorders and B-cell malignancies.
Concentration:
4.67 mg/mL
Molecular Weight:
146.0 kDa
Purity:
99.00% (May vary between batches)
CAS Number:
[679818-59-8]
Target:
Immunology/Inflammation related,Others
* VAT and and shipping costs not included. Errors and price changes excepted